कंपनी का अवलोकन
Nutex Health Inc. operates as a prominent healthcare services and operations entity within the United States, managing a diversified portfolio across three distinct segments: Hospital, Population Health Management, and Real Estate. The company functions within the Healthcare sector, specifically the Medical Care Facilities industry, which encompasses the provision of acute medical care through specialized hospital networks. As of the latest data, the enterprise holds a market capitalization of $727.70M and generates annual revenue totaling $875.26M, supporting an operational workforce of 944 employees. These valuation and revenue figures position the company as a mid-to-large-cap entity in the medical care landscape, indicating a substantial asset base and operational footprint that allows for significant scale in managing hospital facilities and real estate assets.
वित्तीय स्वास्थ्य
The company's financial performance is characterized by a trailing twelve-month revenue of $875.26M, which resulted in a net income of $70.79M and an EBITDA of $413.16M, highlighting a significant operational leverage before interest and taxes. The substantial gap between the revenue figure of $875.26M and the net income of $70.79M reveals a cost structure where operating expenses, including interest costs associated with the $351.39M in debt, consume a large portion of top-line earnings to arrive at the final profit. Despite the net income figure, the company maintains robust free cash flow of $152.81M, which provides essential financial flexibility for capital expenditures, debt servicing, and potential strategic initiatives without relying solely on external financing. Profitability analysis shows a Gross Margin of 53.8%, indicating strong pricing power or cost control on direct service costs, while an Operating Margin of 97.5% suggests extremely efficient overhead management relative to revenue, and a Profit Margin of 8.1% reflects the final bottom-line efficiency after all expenses. Regarding liquidity and leverage, the company holds $185.57M in cash against $351.39M in total debt, resulting in a Debt to Equity ratio of 82.99, which indicates a highly leveraged balance sheet typical of asset-heavy real estate and hospital models. Short-term liquidity is supported by a Current Ratio of 3.41, signifying that the company possesses more than three times the current assets necessary to cover its current liabilities, ensuring it can meet immediate obligations comfortably. Management effectiveness is further evidenced by a Return on Equity of 58.9% and a Return on Assets of 31.2%, metrics that demonstrate the company generates high returns on the capital invested by shareholders and the total asset base utilized in operations.
मूल्यांकन आकलन
Valuation metrics indicate a trailing P/E Ratio (TTM) of 9.82 and a Forward P/E of 5.06, implying that the market expects earnings to increase significantly in the future to justify the lower forward multiple compared to the historical trailing figure. The Price to Book ratio stands at 2.21, suggesting that the stock trades at a premium of 121% over its book value, which may reflect market confidence in the quality of its assets or future growth potential despite current earnings volatility. Alternative valuation measures such as a Price to Sales ratio of 0.83 and an EV/EBITDA of 2.36 suggest the company is valued at less than one dollar of sales and a very low multiple of earnings before interest, taxes, and depreciation, pointing to a potentially undervalued stance relative to traditional metrics if earnings stabilize. The 52-week high is recorded at $193.07 and the low at $77.21, meaning the current trading price sits somewhere within this range, specifically reflecting a recent pullback from the yearly peak of $193.07. The Beta of 2.02 indicates that the stock's price volatility is twice that of the broader market, meaning investors should expect larger swings in price in response to market movements, which aligns with the high-risk profile often seen in leveraged healthcare real estate plays.
Growth & Income
Recent performance data shows a Revenue Growth (YoY) of -41.1% and an Earnings Growth (YoY) of -86.2%, indicating that earnings are contracting at a faster rate than revenue, which implies that cost structures or segment profitability are deteriorating more rapidly than top-line sales are declining. As a non-dividend payer, Nutex Health Inc. reports a Dividend Yield of N/A and a Payout Ratio of 0.0%, confirming that the company retains all of its earnings rather than distributing them to shareholders, thereby prioritizing balance sheet strengthening or organic growth over income generation for investors. The overall growth and income profile is currently defined by significant contraction in both revenue and profitability, with the absence of dividend income forcing investors to rely solely on potential capital appreciation or future earnings stabilization for returns.